Disease-regulated local IL-10 gene therapy diminishes synovitis and cartilage proteoglycan depletion in experimental arthritis

Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis

(2013) Pauline A. van Schouwenburg et al.   Nature Reviews Rheumatology

Disease-Dependent Local IL-10 Production Ameliorates Collagen Induced Arthritis in Mice

(2012) Louise Henningsson et al.   PLoS One

A novel Saa3-promoter reporter distinguishes inflammatory subtypes in experimental arthritis and human synovial fibroblasts

(2011) J. Geurts et al.   ANNALS OF THE RHEUMATIC DISEASES

Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors

(2011) Eleonora Ballanti et al.   AUTOIMMUNITY REVIEWS

Suppressor of cytokine signalling protein SOCS3 expression is increased at sites of acute and chronic inflammation

(2011) Gemma E. White et al.   JOURNAL OF MOLECULAR HISTOLOGY

Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B

(2011) Amit C. Nathwani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Regulation of IL-8 production by complement-activated product, C5a, in vitro and in vivo during sepsis

(2010) Liyan Wang et al.   CLINICAL IMMUNOLOGY

Computational Design and Application of Endogenous Promoters for Transcriptionally Targeted Gene Therapy for Rheumatoid Arthritis

(2009) Jeroen Geurts et al.   MOLECULAR THERAPY

Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis

(2009) Kathrin Schwager et al.   ARTHRITIS RESEARCH & THERAPY